<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39462403</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-3155</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of nanobiotechnology</Title><ISOAbbreviation>J Nanobiotechnology</ISOAbbreviation></Journal><ArticleTitle>S-RBD-modified and miR-486-5p-engineered exosomes derived from mesenchymal stem cells suppress ferroptosis and alleviate radiation-induced lung injury and long-term pulmonary fibrosis.</ArticleTitle><Pagination><StartPage>662</StartPage><MedlinePgn>662</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">662</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12951-024-02830-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Radiation-induced lung injury (RILI) is associated with alveolar epithelial cell death and secondary fibrosis in injured lung. Mesenchymal stem cell (MSC)-derived exosomes have regenerative effect against lung injury and the potential to intervene of RILI. However, their intervention efficacy is limited because they lack lung targeting characters and do not carry sufficient specific effectors. SARS-CoV-2 spike glycoprotein (SARS-CoV-2-S-RBD) binds angiotensin-converting enzyme 2 (ACE2) receptor and mediates interaction with host cells. MiR-486-5p is a multifunctional miRNA with angiogenic and antifibrotic potential and acts as an effector in MSC-derived exosomes. Ferroptosis is a form of cell death associated with radiation injury, its roles and mechanisms in RILI remain unclear. In this study, we developed an engineered MSC-derived exosomes with SARS-CoV-2-S-RBD- and miR-486-5p- modification and investigated their intervention effects on RIPF and action mechanisms via suppression of epithelial cell ferroptosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Adenovirus-mediated gene modification led to miR-486-5p overexpression in human umbilical cord MSC exosomes (p &lt; 0.05), thereby constructing miR-486-5p engineered MSC exosomes (miR-486-MSC-Exo). MiR-486-MSC-Exo promoted the proliferation and migration of irradiated mouse lung epithelial (MLE-12) cells in vitro and inhibited RILI in vivo (all p &lt; 0.05). MiR-486-MSC-Exo suppressed ferroptosis in MLE-12 cells, and an in vitro assay revealed that the expression of fibrosis-related genes is up-regulated following ferroptosis (both p &lt; 0.05). MiR-486-MSC-Exo reversed the up-regulated expression of fibrosis-related genes induced by TGF-β1 in vitro and improved pathological fibrosis in RIPF mice in vivo (all p &lt; 0.05). SARS-CoV-2-S-RBD-modified and miR-486-5p-engineered MSC exosomes (miR-486-RBD-MSC-Exo) were also constructed, and the distribution of DiR dye-labeled miR-486-RBD-MSC-Exo in hACE2<sup>CKI/CKI</sup> Sftpc-Cre<sup>+</sup> mice demonstrated long-term retention in the lung (p &lt; 0.05). MiR-486-RBD-MSC-Exo significantly improved the survival rate and pathological changes in hACE2<sup>CKI/CKI</sup> Sftpc-Cre<sup>+</sup> RIPF mice (all p &lt; 0.05). Furthermore, miR-486-MSC-Exo exerted anti-fibrotic effects via targeted SMAD2 inhibition and Akt phosphorylation activation (p &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Engineered MSC exosomes with SARS-CoV-2-S-RBD- and miR-486-5p-modification were developed. MiR-486-RBD-MSC-Exo suppressed ferroptosis and fibrosis of MLE-12 cells in vitro, and alleviated RILI and long-term RIPF in ACE2 humanized mice in vivo. MiR-486-MSC-Exo exerted anti-fibrotic effects via SMAD2 inhibition and Akt activation. This study provides a potential approach for RIPF intervention.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei-Yuan</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Special Medicine, School of Basic Medicine, Qingdao University, Qingdao, 266071, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Molecular Diagnosis and Regenerative Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Nursing, Jilin University, Changchun, 130021, Jilin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ting Ting</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Special Medicine, School of Basic Medicine, Qingdao University, Qingdao, 266071, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Molecular Diagnosis and Regenerative Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yi-Zhu</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yu-Xin</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Xiao-Chen</ForeName><Initials>XC</Initials><AffiliationInfo><Affiliation>Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Hui-Yan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Yanda Medical Research Institute, Hebei Yanda Hospital, Langfang, 065201, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Feng-Jun</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China. xiaofjun@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li-Sheng</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Special Medicine, School of Basic Medicine, Qingdao University, Qingdao, 266071, People's Republic of China. lishengwang@qdu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Molecular Diagnosis and Regenerative Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266000, People's Republic of China. lishengwang@qdu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, Jilin University, Changchun, 130021, Jilin, People's Republic of China. lishengwang@qdu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>H2024103005</GrantID><Agency>Natural Science Foundation of Hebei Province</Agency><Country /></Grant><Grant><GrantID>22567663H</GrantID><Agency>Science and Technology Enhancement Program of Heibei Province</Agency><Country /></Grant><Grant><GrantID>82073489</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>ZR2020MH327</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Nanobiotechnology</MedlineTA><NlmUniqueID>101152208</NlmUniqueID><ISSNLinking>1477-3155</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C560945">MIRN486 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079403" MajorTopicYN="Y">Ferroptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="Y">Mesenchymal Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011658" MajorTopicYN="Y">Pulmonary Fibrosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="N">Lung Injury</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011832" MajorTopicYN="N">Radiation Injuries</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Engineered exosomes</Keyword><Keyword MajorTopicYN="N">Ferroptosis</Keyword><Keyword MajorTopicYN="N">Mesenchymal stem cells</Keyword><Keyword MajorTopicYN="N">MiR-486-5p</Keyword><Keyword MajorTopicYN="N">Pulmonary fibrosis</Keyword><Keyword MajorTopicYN="N">Radiation-induced pulmonary injury</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2-S-RBD</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>13</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39462403</ArticleId><ArticleId IdType="doi">10.1186/s12951-024-02830-9</ArticleId><ArticleId IdType="pii">10.1186/s12951-024-02830-9</ArticleId><ArticleId IdType="pmc">PMC11515248</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury: assessment and management. Chest. 2019;156:150–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8097634</ArticleId><ArticleId IdType="pubmed">30998908</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Fu J, Kowalchuk RO, Wright CM, Zhang R, Li X, Xu Y. Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review. Transl Lung Cancer Res. 2022;11:307–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8902083</ArticleId><ArticleId IdType="pubmed">35280316</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N, Cho SG. Clinical applications of mesenchymal stem cells. Korean J Intern Med. 2013;28:387–402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712145</ArticleId><ArticleId IdType="pubmed">23864795</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanoni M, Cortesi M, Zamagni A, Tesei A. The role of mesenchymal stem cells in radiation-induced lung fibrosis. Int J Mol Sci. 2019;20(16):3876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6719901</ArticleId><ArticleId IdType="pubmed">31398940</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Feng Z, Wang FS. Mesenchymal stem cell treatment for COVID-19. EBioMedicine. 2022;77: 103920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8907937</ArticleId><ArticleId IdType="pubmed">35279630</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J, Jiang X, Li W, Ren J, Wang D, Ji Z, Wu Z, Cheng F, Cai Y, Yu ZR, et al. Exosomes from antler stem cells alleviate mesenchymal stem cell senescence and osteoarthritis. Protein Cell. 2022;13:220–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8901817</ArticleId><ArticleId IdType="pubmed">34342820</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Lei B, Zhang E, Gong P, Gu J, He L, Han L, Yuan Z. Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics. Int J Nanomedicine. 2022;17:1757–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034888</ArticleId><ArticleId IdType="pubmed">35469174</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruonan X, Zhiqian F, Fu-Sheng W: Mesenchymal stem cell treatment for COVID-19. EBioMedicine 2022, 77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8907937</ArticleId><ArticleId IdType="pubmed">35279630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruenn Chai L, Ronne Wee Yeh Y, Sai Kiang L: Mesenchymal stem cell exosomes. Semin Cell Dev Biol 2015, 40.</Citation><ArticleIdList><ArticleId IdType="pubmed">25765629</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan J, Kumar P, Hao D, Gao K, Farmer D, Wang A. Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy. J Extracell Vesicles. 2018;7:1522236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6161586</ArticleId><ArticleId IdType="pubmed">30275938</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou G, Chen L, Xia C, Wang W, Qi J, Li A, Zhao L, Chen Z, Zheng M, Liu Y. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. J Exp Clin Cancer Res. 2020;39:1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6941283</ArticleId><ArticleId IdType="pubmed">31898515</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Driedonks TAP, Jong WSP, Dhakal S, van den Berg B, van Saparoea H, Sitaras I, Zhou R, Caputo C, Littlefield K, Lowman M, et al. A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants. J Extracell Vesicles. 2022;11:12192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8920961</ArticleId><ArticleId IdType="pubmed">35289114</ArticleId></ArticleIdList></Reference><Reference><Citation>Popowski KD, Moatti A, Scull G, Silkstone D, Lutz H, de Juan L, Abad B, George A, Belcher E, Zhu D, Mei X, et al. Inhalable dry powder mRNA vaccines based on extracellular vesicles. Matter. 2022;5:2960–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9272513</ArticleId><ArticleId IdType="pubmed">35847197</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Pan X, Li L, Yu F, Zheng A, Du P, Han P, Meng Y, Zhang Y, Wu L, et al. Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell. 2021;184(3438–3451): e3410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142884</ArticleId><ArticleId IdType="pubmed">34139177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz M, Thurman A, Pezzulo A, Leidinger M, Klesney-Tait J, Karp P, Tan P, Wohlford-Lenane C, McCray P, Meyerholz D. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020;60: 102976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7505653</ArticleId><ArticleId IdType="pubmed">32971472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler CG, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, Feldman J. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181(5):1016–35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Liu P, Jiang Y, Wang Z, Dai H, Wang C. Therapeutic applications of mesenchymal stem cells in idiopathic pulmonary fibrosis. Front Cell Dev Biol. 2021;9: 639657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7985078</ArticleId><ArticleId IdType="pubmed">33768094</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu H, Tie Y, Xu C, Zhang Z, Zhu J, Shi Y, Jiang H, Sun Z, Zheng X. Identification of human fetal liver miRNAs by a novel method. FEBS Lett. 2005;579:3849–54.</Citation><ArticleIdList><ArticleId IdType="pubmed">15978578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LS, Li L, Li L, Chu S, Shiang KD, Li M, Sun HY, Xu J, Xiao FJ, Sun G, et al. MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors. Blood. 2015;125:1302–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4335083</ArticleId><ArticleId IdType="pubmed">25515961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Lee C, Shin Y, Wang S, Han J, Kim M, Kim JM, Shin SC, Lee BJ, Kim TJ, Jung Y. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p. Mol Therapy. 2021;29(4):1471–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8058446</ArticleId><ArticleId IdType="pubmed">33348053</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji X, Wu B, Fan J, Han R, Luo C, Wang T, Yang J, Han L, Zhu B, Wei D, et al. The anti-fibrotic effects and mechanisms of MicroRNA-486-5p in pulmonary fibrosis. Sci Rep. 2015;5:14131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4569899</ArticleId><ArticleId IdType="pubmed">26370615</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Ao X, Liang X, Chen Z, Liu Y, Wang P, Wang D, Liu Z, Liu X, Zhu J, et al. Transcriptional inhibition of miR-486-3p by BCL6 upregulates Snail and induces epithelial-mesenchymal transition during radiation-induced pulmonary fibrosis. Respir Res. 2022;23:104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9052631</ArticleId><ArticleId IdType="pubmed">35484551</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Liu C, Ji HL. Concise review: therapeutic potential of the mesenchymal stem cell derived secretome and extracellular vesicles for radiation-induced lung injury: progress and hypotheses. Stem Cells Transl Med. 2019;8:344–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431606</ArticleId><ArticleId IdType="pubmed">30618085</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan ZH, Liu T, Wang H, Xue LX, Wang JJ. Fatty acids metabolism: the bridge between ferroptosis and ionizing radiation. Front Cell Dev Biol. 2021;9: 675617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8264768</ArticleId><ArticleId IdType="pubmed">34249928</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Song Y, Wei L, Guo J, Xu W, Li M. The emerging roles of ferroptosis in organ fibrosis and its potential therapeutic effect. Int Immunopharmacol. 2023;116: 109812.</Citation><ArticleIdList><ArticleId IdType="pubmed">36746022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi N, Adelian S, Shakerian S, Afshinpour M, Chaleshtori SR, Rostami N, Rezaei-Tazangi F, Beiranvand S, Hamblin MR, Aref AR. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy. Cytokine Growth Factor Rev. 2022;64:33–45.</Citation><ArticleIdList><ArticleId IdType="pubmed">35219587</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei Z, Qin Y, Fu X, Yang F, Huo F, Liang X, Wang S, Cui H, Lin P, Zhou G, et al. Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model. Redox Biol. 2022;57: 102509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614651</ArticleId><ArticleId IdType="pubmed">36302319</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L, Shi X, Sun H, Li Y, Xiao F, Wang H, Wang L. Effects of exosomes derived from miR-486 gene modified umbilical cord mesenchymal stem cells on biological characteristics of rat cardiomyocytes. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018;26:1531–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30295279</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Xiong S. Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection. J Control Release. 2021;335:584–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172277</ArticleId><ArticleId IdType="pubmed">34089793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying H, Fang M, Hang QQ, Chen Y, Qian X, Chen M. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-beta1/Smad3 pathway. J Cell Mol Med. 2021;25:8662–75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8435416</ArticleId><ArticleId IdType="pubmed">34327818</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L, Zhu Q, Xu C, Li M, Li H, Yi PQ, Xu FF, Cao L, Chen JY. Glycyrrhizin mitigates radiation-induced acute lung injury by inhibiting the HMGB1/TLR4 signalling pathway. J Cell Mol Med. 2020;24:214–26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6933400</ArticleId><ArticleId IdType="pubmed">31657123</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun XH, Wang X, Zhang Y, Hui J. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway. Thromb Res. 2019;177:23–32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30844685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou G, Chen L, Xia C, Wang W, Qi J, Li A, Zhao L, Chen Z, Zheng M, Liu Y. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. J Exp Clin Cancer Res. 2020;39:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6941283</ArticleId><ArticleId IdType="pubmed">31898515</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Li C, Zhu M, Zhang Y, Du J, Xu Y, Liu B, Gao F, Liu H, Cai J, Yang Y. Hypoxia-induced mesenchymal stromal cells exhibit an enhanced therapeutic effect on radiation-induced lung injury in mice due to an increased proliferation potential and enhanced antioxidant ability. Cell Physiol Biochem. 2017;44:1295–310.</Citation><ArticleIdList><ArticleId IdType="pubmed">29183009</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Popowski KD, Zhu D, de Juan Abad BL, Wang X, Liu M, Lutz H, De Naeyer N, DeMarco CT, Denny TN, et al. Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine. Nat Biomed Eng. 2022;6:791–805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10782831</ArticleId><ArticleId IdType="pubmed">35788687</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzaka Y, Yashiro R. Therapeutic strategy of mesenchymal-stem-cell-derived extracellular vesicles as regenerative medicine. Int J Mol Sci. 2022;23(12):6480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9224400</ArticleId><ArticleId IdType="pubmed">35742923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016-1035.e1019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, Navarro MJ, Bowen JE, Tortorici MA, Walls AC, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020;182(1295–1310): e1220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418704</ArticleId><ArticleId IdType="pubmed">32841599</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shennawy L, Hoffmann AD, Dashzeveg NK, McAndrews KM, Mehl PJ, Cornish D, Yu Z, Tokars VL, Nicolaescu V, Tomatsidou A, et al. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat Commun. 2022;13:405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776790</ArticleId><ArticleId IdType="pubmed">35058437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Wei J, Meng L, Wang H, Qu C, Chen X, Xin Y, Jiang X. Advances in pathogenic mechanisms and management of radiation-induced fibrosis. Biomed Pharmacother. 2020;121: 109560.</Citation><ArticleIdList><ArticleId IdType="pubmed">31739160</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Zhang W, Yu F, Gao F. The cellular and molecular mechanism of radiation-induced lung injury. Med Sci Monit. 2017;23:3446–50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5523971</ArticleId><ArticleId IdType="pubmed">28710886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hade MD, Suire CN, Suo Z. Mesenchymal stem cell-derived exosomes: applications in regenerative medicine. Cells. 2021;10(8):1959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8393426</ArticleId><ArticleId IdType="pubmed">34440728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T, Sun F, Liu J, Ding T, She J, Mao F, Xu W, Qian H, Yan Y. Emerging role of mesenchymal stem cell-derived exosomes in regenerative medicine. Curr Stem Cell Res Ther. 2019;14:482–94.</Citation><ArticleIdList><ArticleId IdType="pubmed">30819086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SM, Jeong CH, Woo JS, Ryu CH, Lee JH, Jeun SS. In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution. Int J Nanomedicine. 2016;11:13–23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690647</ArticleId><ArticleId IdType="pubmed">26719691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, Chen YA, Ke CC, Chiu SJ, Chen CC, Hsieh YJ, Yang BH, Liu RS. Preclinical characterization and in vivo imaging of (111)in-labeled mesenchymal stem cell-derived extracellular vesicles. Mol Imaging Biol. 2021;23:361–71.</Citation><ArticleIdList><ArticleId IdType="pubmed">33216285</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai SJ, Atai NA, Cacciottolo M, Nice J, Salehi A, Guo C, Sedgwick A, Kanagavelu S, Gould SJ. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity. J Biol Chem. 2021;297(5):101266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8483990</ArticleId><ArticleId IdType="pubmed">34600888</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo JB, Looi QH, How CW, Lee SH, Al-Masawa ME, Chong PP, Law JX. Mesenchymal stem cell-derived exosomes and micrornas in cartilage regeneration: biogenesis, efficacy, mirna enrichment and delivery. Pharmaceuticals. 2021;14(11):1093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8618513</ArticleId><ArticleId IdType="pubmed">34832875</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Jia Y, Kong X, Nie Y, Deng Y, Liu Y. Novel drug delivery systems and disease models for pulmonary fibrosis. J Controlled Release. 2022;348:95–114.</Citation><ArticleIdList><ArticleId IdType="pubmed">35636615</ArticleId></ArticleIdList></Reference><Reference><Citation>Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS ONE. 2009;4: e8003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2777376</ArticleId><ArticleId IdType="pubmed">19946373</ArticleId></ArticleIdList></Reference><Reference><Citation>Douvris A, Vinas J, Burns KD. miRNA-486-5p: signaling targets and role in non-malignant disease. Cell Mol Life Sci. 2022;79:376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9217846</ArticleId><ArticleId IdType="pubmed">35731367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Liu C, Yao R, Tan Q, Wang Q, Tian H. MiR-486-5p suppresses gastric cancer cell growth and migration through downregulation of fibroblast growth factor 9. Mol Med Rep. 2021;24(5):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8436225</ArticleId><ArticleId IdType="pubmed">34490480</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen TA, Huang HC, Wu ET, Chou HW, Chou HC, Chen CY, Huang SC, Chen YS, Lu F, Wu MH, Tsao PN. Microrna-486-5P regulates human pulmonary artery smooth muscle cell migration via endothelin-1. Int J Mol Sci. 2022;23(18):10400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499400</ArticleId><ArticleId IdType="pubmed">36142307</ArticleId></ArticleIdList></Reference><Reference><Citation>Deleon N, Adem S, Lavin C, Abbas D, Griffin M, King M, Borrelli M, Patel R, Fahy E, Lee D, et al. Angiogenic CD34+CD146+ adipose-derived stromal cells augment recovery of soft tissue after radiotherapy. J Tissue Eng Regen Med. 2021;15:1105–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8988387</ArticleId><ArticleId IdType="pubmed">34582109</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Shi Y, Gong J, Zhao L, Li Y, He Q, Huang H. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther. 2019;10:95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6419838</ArticleId><ArticleId IdType="pubmed">30876481</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y. viaMiR-486-5p inhibits the hyperproliferation and production of collagen in hypertrophic scar fibroblasts IGF1/PI3K/AKT pathway. J Dermatolog Treat. 2021;32:973–82.</Citation><ArticleIdList><ArticleId IdType="pubmed">32079424</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Zhang Y, Long H, Zhou B, Jiang H. βmiR-486-5p restrains extracellular matrix production and oxidative damage in human trabecular meshwork cells by targeting TGF-/SMAD2 pathway. J Ophthalmol. 2022;2022:3584192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8890899</ArticleId><ArticleId IdType="pubmed">35251709</ArticleId></ArticleIdList></Reference><Reference><Citation>Viñas JL, Spence M, Porter CJ, Douvris A, Gutsol A, Zimpelmann JA, Campbell PA, Burns KD. micro-RNA-486-5p protects against kidney ischemic injury and modifies the apoptotic transcriptome in proximal tubules. Kidney Int. 2021;100:597–612.</Citation><ArticleIdList><ArticleId IdType="pubmed">34181969</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Tan H, Daniels JD, Zandkarimi F, Liu H, Brown LM, Uchida K, O’Connor OA, Stockwell BR. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem Biol. 2019;26(5):623–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6525071</ArticleId><ArticleId IdType="pubmed">30799221</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao FJ, Zhang D, Wu Y, Jia QH, Zhang L, Li YX, Yang YF, Wang H, Wu CT, Wang LS. miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis. Biochem Biophys Res Commun. 2019;515:448–54.</Citation><ArticleIdList><ArticleId IdType="pubmed">31160087</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F, Chen W, Zhou J, Zhu J, Yao Q, Feng B, Feng X, Shi X, Pan Q, Yu J, et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis. 2022;13:271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8960810</ArticleId><ArticleId IdType="pubmed">35347117</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Duan L, Yuan S, Zhuang X, Qiao T, He J. Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1. J Inflamm (Lond). 2019;16:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6542066</ArticleId><ArticleId IdType="pubmed">31160885</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleksandr K, Ashley Rose R, David N, Daniel C, Heather M-M, Robert Matthew K: Association between weight loss and mortality in idiopathic pulmonary fibrosis. Respir Res 2022,23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9790113</ArticleId><ArticleId IdType="pubmed">36566185</ArticleId></ArticleIdList></Reference><Reference><Citation>Douvris A, Viñas J, Burns KD. miRNA-486-5p: signaling targets and role in non-malignant disease. Cell Mol Life Sci. 2022;79(7):376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9217846</ArticleId><ArticleId IdType="pubmed">35731367</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Li K, Zhong X, Wang G, Wang X, Cheng M, Chen J, Chen Z, Chen J, Zhang C, Xiong G. Sox9-expressing cells promote regeneration after radiation-induced lung injury via the PI3K/AKT pathway. Stem Cell Res Therapy. 2021;12(1):381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8254240</ArticleId><ArticleId IdType="pubmed">34215344</ArticleId></ArticleIdList></Reference><Reference><Citation>Viñas J, Burger D, Zimpelmann J, Haneef R, Knoll W, Campbell P, Gutsol A, Carter A, Allan D, Burns K. Transfer of microRNA-486-5p from human endothelial colony forming cell-derived exosomes reduces ischemic kidney injury. Kidney Int. 2016;90:1238–50.</Citation><ArticleIdList><ArticleId IdType="pubmed">27650731</ArticleId></ArticleIdList></Reference><Reference><Citation>Viñas J, Spence M, Gutsol A, Knoll W, Burger D, Zimpelmann J, Allan D, Burns K. Receptor-ligand interaction mediates targeting of endothelial colony forming cell-derived exosomes to the kidney after ischemic injury. Sci Rep. 2018;8:16320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6218514</ArticleId><ArticleId IdType="pubmed">30397255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>